Grants and Contributions:

Back to search

Title:

P008256001: CXI - iProgen Biotech Inc. 2019-2020 P008256002: CXI - iProgen Biotech Inc. 2019-2020

Agreement Number:

7411895 P008256001 P008256002

Agreement Value:

$7,205.00

Agreement Date:

Sep 25, 2019 - Mar 31, 2020

Description:

P008256001: The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies. P008256002: The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.

Organization:

Global Affairs Canada

Expected Results:

P008256001: Increase Canadian science and technological innovation and commercialization opportunities as measured by analysis of recipient performance reports and surveys.

P008256002: Increase Canadian science and technological innovation and commercialization opportunities as measured by analysis of recipient performance reports and surveys.

Location:

Burnaby, British Columbia, CA V5A 4N4

Reference Number:

064-2019-2020-Q2-00173

Agreement Type:

Grant

Report Type:

Grants and Contributions

Recipient Business Number:

826908816

Recipient Type:

For-profit organization

Recipient's Legal Name:

iProgen Biotech Inc.

Federal Riding Name:

Burnaby North--Seymour

Federal Riding Number:

59002

Program:

P008256001 & P008256002: CanExport - Innovation

Program Purpose:

P008256001 & P008256002: Promote and enhance Canada’s international innovation efforts by supporting innovators (employees of academic institutions, Canadian companies and non-government research centres that are seeking to commercialize technology) pursue international Research and Development (R&D) collaborative opportunities through the development of partnerships with key players in other countries/economies.